# CRUZ Tunisia-Multivessel Registry

> **NCT06663696** · — · RECRUITING · sponsor: **Sahajanand Medical Technologies Limited** · enrollment: 1000 (estimated)

## Conditions studied

- Patient Population With Multivessel Disease

## Interventions

- **DEVICE:** Supraflex Cruz Sirolimus-eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT06663696
- **Lead sponsor:** Sahajanand Medical Technologies Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2027-11
- **Final completion:** 2028-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06663696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06663696, "CRUZ Tunisia-Multivessel Registry". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06663696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*